|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
|
US20030007954A1
(en)
|
1999-04-12 |
2003-01-09 |
Gail K. Naughton |
Methods for using a three-dimensional stromal tissue to promote angiogenesis
|
|
JP5140220B2
(ja)
*
|
1999-05-27 |
2013-02-06 |
バイオコンパテイブルズ・ユーケイ・リミテツド |
局所的な薬剤送達
|
|
ATE355824T1
(de)
|
2000-01-11 |
2007-03-15 |
Roland Bodmeier |
Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US8460367B2
(en)
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
DE10044545A1
(de)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
|
DE60131177T2
(de)
|
2000-09-06 |
2008-08-07 |
AP Pharma, Inc., Redwood |
Abbaubare polyacetal-polymere
|
|
DE60133053T2
(de)
|
2000-10-16 |
2009-02-26 |
Conor Medsystems, Inc., Menlo Park |
Ausdehnbare medizinische Vorrichtung zur Abgabe eines nützlichen Agens
|
|
WO2002038185A2
(en)
*
|
2000-11-13 |
2002-05-16 |
Atrix Laboratories, Inc. |
Injectable sustained release delivery system with loperamide
|
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
|
US8158106B2
(en)
*
|
2001-10-05 |
2012-04-17 |
Surmodics, Inc. |
Particle immobilized coatings and uses thereof
|
|
US6755869B2
(en)
*
|
2001-11-09 |
2004-06-29 |
Boston Scientific Corporation |
Intragastric prosthesis for the treatment of morbid obesity
|
|
JP4346441B2
(ja)
|
2001-11-15 |
2009-10-21 |
バイオマテラ インコーポレイテッド |
ゲルの調製方法
|
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
|
EP1344538A1
(de)
*
|
2002-03-14 |
2003-09-17 |
Degradable Solutions AG |
Poröses und bioabbaubares Implantatmaterial und Verfahren zu seiner Herstellung
|
|
AU2003218307B8
(en)
*
|
2002-03-20 |
2006-08-31 |
Alkermes, Inc. |
Pulmonary delivery for levodopa
|
|
DK1359247T3
(da)
*
|
2002-04-30 |
2006-02-13 |
Cognis Ip Man Gmbh |
Med mikrokapsler behandlede fibre og flade tekstilprodukter
|
|
US7432245B2
(en)
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
|
AU2003272284B2
(en)
*
|
2002-09-05 |
2009-03-05 |
Catherine G. Ambrose |
Antibiotic microspheres for treatment of infections and osteomyelitis
|
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
|
US6883194B2
(en)
|
2002-11-08 |
2005-04-26 |
Art Advanced Research And Technology Inc. |
Method and apparatus for positioning a patient on a table for a medical procedure on a breast
|
|
EP1596767B1
(de)
|
2003-02-12 |
2018-10-03 |
Syncera, Inc. |
Statistische und nichtstatistische alkylenoxid-polymer-legierungszusammensetzungen
|
|
JP2007525429A
(ja)
*
|
2003-03-11 |
2007-09-06 |
キューエルティー ユーエスエー，インコーポレイテッド． |
細胞スケジュール依存性抗癌剤のための処方
|
|
EP1610823B1
(de)
|
2003-03-28 |
2011-09-28 |
Innovational Holdings, LLC |
Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
|
|
DE10314082A1
(de)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradierbares injizierbares Implantat
|
|
US20040202694A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Vascular Control Systems, Inc. |
Embolic occlusion of uterine arteries
|
|
CA2521623C
(en)
|
2003-04-11 |
2015-03-17 |
Etex Corporation |
Osteoinductive bone material
|
|
US20050038501A1
(en)
*
|
2003-08-12 |
2005-02-17 |
Moore James E. |
Dynamic stent
|
|
AU2004279319B2
(en)
*
|
2003-09-23 |
2010-11-04 |
Abyrx, Inc |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
|
US7989000B2
(en)
*
|
2003-09-23 |
2011-08-02 |
Orthocon, Inc. |
Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects
|
|
US7955616B2
(en)
*
|
2003-09-23 |
2011-06-07 |
Orthocon, Inc. |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US8673021B2
(en)
*
|
2003-11-26 |
2014-03-18 |
Depuy Mitek, Llc |
Arthroscopic tissue scaffold delivery device
|
|
KR20050054129A
(ko)
*
|
2003-12-04 |
2005-06-10 |
주식회사 삼양사 |
고분자 미셀을 형성하는 생분해성 분지형 폴리락트산유도체, 및 그의 제조방법 및 용도
|
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
|
US7976847B2
(en)
*
|
2004-01-13 |
2011-07-12 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release CGRP delivery composition for cardiovascular and renal indications
|
|
EP1703916A2
(de)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Verfahren zur behandlung eines akuten myokardinfarkts mit einem mit dem calicitonin-gen in verbindung stehenden peptid sowie dieses enthaltende zusammensetzungen
|
|
JP2007517911A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ， インコーポレイテッド |
心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法
|
|
DE602005011928D1
(de)
|
2004-01-20 |
2009-02-05 |
Allergan Inc |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
|
US20050214339A1
(en)
*
|
2004-03-29 |
2005-09-29 |
Yiwen Tang |
Biologically degradable compositions for medical applications
|
|
JP2007533376A
(ja)
*
|
2004-04-15 |
2007-11-22 |
エテックス コーポレーション |
遅延凝固リン酸カルシウムペースト
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8163030B2
(en)
*
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
|
US20050255045A1
(en)
*
|
2004-05-13 |
2005-11-17 |
Woltering Eugene A |
Surgical marking composition and method
|
|
EP1604693A1
(de)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In-situ hergestelltes Gerüst, dessen Herstellungsverfahren und dessen Verwendung
|
|
WO2006017347A2
(en)
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
DE602005013244D1
(de)
*
|
2004-08-12 |
2009-04-23 |
Quest Pharmaceutical Services |
Pharmazeutische zusammensetzungen für die kontroll
|
|
US20060154365A1
(en)
*
|
2004-08-30 |
2006-07-13 |
Anthony Ratcliffe |
Cultured three dimensional tissues and uses thereof
|
|
US20080226604A9
(en)
*
|
2005-06-17 |
2008-09-18 |
Theregen Company |
Methods for treating ischemic tissue
|
|
AU2005279934A1
(en)
*
|
2004-08-30 |
2006-03-09 |
Theregen, Inc. |
Compositions and methods of promoting hair growth
|
|
US20060045902A1
(en)
*
|
2004-09-01 |
2006-03-02 |
Serbousek Jon C |
Polymeric wrap for in vivo delivery of osteoinductive formulations
|
|
US8603528B2
(en)
*
|
2004-09-16 |
2013-12-10 |
Abyrx, Inc. |
Compositions and method for the reduction of post-operative pain
|
|
US20060057184A1
(en)
*
|
2004-09-16 |
2006-03-16 |
Nycz Jeffrey H |
Process to treat avascular necrosis (AVN) with osteoinductive materials
|
|
US20060062811A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Szymczak Christopher E |
Medicinal cooling emulsions
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
MX2007003789A
(es)
*
|
2004-10-04 |
2007-07-20 |
Qlt Usa Inc |
Suministro ocular de formulaciones polimericas para suministro.
|
|
US20060079954A1
(en)
*
|
2004-10-08 |
2006-04-13 |
Robert Burgermeister |
Geometry and material for high strength, high flexibility, controlled recoil stent
|
|
ATE450276T1
(de)
*
|
2004-12-08 |
2009-12-15 |
Pervasis Therapeutics Inc |
Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung
|
|
WO2006062871A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Pervasis Therapeutics, Inc. |
Materials and methods for minimally-invasive administration of a cell-containing flowable composition
|
|
US20060129226A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Robert Burgermeister |
Material for flexible connectors in high strength, high flexibility, controlled recoil stent
|
|
US20070036843A1
(en)
*
|
2005-01-28 |
2007-02-15 |
Collegium Pharmaceutical, Inc. |
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
|
|
CA2498623A1
(en)
*
|
2005-02-18 |
2006-08-18 |
Qlt Inc. |
Treatment of onychomycosis
|
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
|
US20100087546A1
(en)
*
|
2005-04-20 |
2010-04-08 |
Biogenic Innovations, Llc |
Use of dimethyl sulfone (msm) to reduce homocysteine levels
|
|
CA2605080A1
(en)
*
|
2005-04-21 |
2006-11-02 |
Massachusetts Institute Of Technology |
Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
|
|
EP2361591A3
(de)
*
|
2005-06-21 |
2011-12-21 |
Pervasis Therapeutics, Inc. |
Verfahren und Zusammensetzungen zur Verbesserung des vaskulären Zugangs
|
|
CA2616384A1
(en)
*
|
2005-07-25 |
2007-02-01 |
Orthocon, Inc. |
Compositions and methods for the reduction of post-operative pain
|
|
AU2006275702A1
(en)
|
2005-07-29 |
2007-02-08 |
Concert Pharmaceuticals Inc. |
Novel pharmaceutical compounds
|
|
AU2006291134C1
(en)
|
2005-09-12 |
2013-08-15 |
Abela Pharmaceuticals, Inc. |
Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
|
|
WO2007033082A2
(en)
|
2005-09-12 |
2007-03-22 |
Abela Pharmaceuticals, Inc. |
Compositions comprising dimethyl sulfoxide (dmso)
|
|
US8435224B2
(en)
|
2005-09-12 |
2013-05-07 |
Abela Pharmaceuticals, Inc. |
Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
|
|
US8480797B2
(en)
|
2005-09-12 |
2013-07-09 |
Abela Pharmaceuticals, Inc. |
Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
WO2007142667A2
(en)
|
2005-10-13 |
2007-12-13 |
Human Genome Sciences, Inc. |
Treatment of patients with autoantibody positive disease
|
|
WO2007067624A2
(en)
|
2005-12-06 |
2007-06-14 |
Tyco Healthcare Group Lp |
Bioabsorbable compounds and compositions containing them
|
|
US7947263B2
(en)
*
|
2005-12-06 |
2011-05-24 |
Tyco Healthcare Group Lp |
Biocompatible surgical compositions
|
|
EP2633834A1
(de)
*
|
2005-12-06 |
2013-09-04 |
Covidien LP |
Bioabsorbierbare chirurgische Zusammensetzung
|
|
US20100204783A1
(en)
*
|
2005-12-06 |
2010-08-12 |
Helen Marie Nugent |
Methods and compositions for enhancing vascular access
|
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
|
JP2009518519A
(ja)
*
|
2005-12-06 |
2009-05-07 |
タイコ ヘルスケア グループ リミテッド パートナーシップ |
官能化ポリエチレングリコールのカルボジイミド架橋
|
|
AU2006321913B2
(en)
*
|
2005-12-06 |
2012-08-02 |
Covidien Lp |
Biocompatible tissue sealants and adhesives
|
|
JP2009518138A
(ja)
*
|
2005-12-08 |
2009-05-07 |
タイコ ヘルスケア グループ リミテッド パートナーシップ |
生体適合性外科用組成物
|
|
CA2630327C
(en)
|
2005-12-08 |
2015-05-26 |
Tyco Healthcare Group Lp |
Biocompatible surgical compositons
|
|
EP1966311A4
(de)
*
|
2005-12-08 |
2012-08-15 |
Tyco Healthcare |
Versprühbare zusammensetzungen mit verringerter viskosität
|
|
WO2007084460A2
(en)
*
|
2006-01-18 |
2007-07-26 |
Qps, Llc |
Pharmaceutical compositions with enhanced stability
|
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US8486135B2
(en)
*
|
2006-06-01 |
2013-07-16 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices fabricated from branched polymers
|
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|
|
US8748419B2
(en)
|
2006-06-16 |
2014-06-10 |
Theracos, Inc. |
Treating obesity with muscarinic receptor M1 antagonists
|
|
US20080003250A1
(en)
*
|
2006-06-21 |
2008-01-03 |
Margulies Barry J |
Novel therapy for herpesvirus infection
|
|
US8206735B2
(en)
*
|
2006-07-11 |
2012-06-26 |
Foresee Pharmaceuticals, Llc |
Pharmaceutical compositions for sustained release delivery of peptides
|
|
US7794495B2
(en)
*
|
2006-07-17 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Controlled degradation of stents
|
|
US8076448B2
(en)
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
JP5372764B2
(ja)
*
|
2006-11-07 |
2013-12-18 |
シャイア リジェネラティブ メディシン， インコーポレイテッド |
血管形成関連疾患の治療および管理のための材料および方法
|
|
US20090263346A1
(en)
*
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
|
US20100004124A1
(en)
*
|
2006-12-05 |
2010-01-07 |
David Taft |
Systems and methods for delivery of materials for agriculture and aquaculture
|
|
EP2500015A1
(de)
*
|
2006-12-05 |
2012-09-19 |
Landec Corporation |
Verabreichung von Arzneimitteln
|
|
US20090246155A1
(en)
*
|
2006-12-05 |
2009-10-01 |
Landec Corporation |
Compositions and methods for personal care
|
|
US8399007B2
(en)
*
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
|
JP2010516680A
(ja)
|
2007-01-19 |
2010-05-20 |
エックスカバリー，インコーポレイテッド |
キナーゼ阻害薬化合物
|
|
DK3660073T3
(da)
|
2007-02-15 |
2023-09-18 |
Tolmar International Ltd |
Poly(lactid-co-glycolid) med lav sprængning
|
|
JP5583003B2
(ja)
|
2007-04-02 |
2014-09-03 |
セラコス・インコーポレイテッド |
ベンジルグルコシド誘導体およびその用途
|
|
ES2562878T3
(es)
|
2007-05-25 |
2016-03-08 |
Indivior Uk Limited |
Formulaciones de liberación sostenida de compuestos de risperidona
|
|
US20100185156A1
(en)
*
|
2007-06-13 |
2010-07-22 |
Pervasis Therapeutics, Inc. |
Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions
|
|
US8133553B2
(en)
|
2007-06-18 |
2012-03-13 |
Zimmer, Inc. |
Process for forming a ceramic layer
|
|
US8309521B2
(en)
|
2007-06-19 |
2012-11-13 |
Zimmer, Inc. |
Spacer with a coating thereon for use with an implant device
|
|
US8182647B2
(en)
|
2007-07-23 |
2012-05-22 |
Cohera Medical, Inc. |
Hydrophilic biodegradable adhesives
|
|
NZ583369A
(en)
|
2007-08-23 |
2011-08-26 |
Theracos Inc |
Benzylbenzene derivatives and methods of use
|
|
US8470360B2
(en)
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
|
US20110230973A1
(en)
*
|
2007-10-10 |
2011-09-22 |
Zimmer, Inc. |
Method for bonding a tantalum structure to a cobalt-alloy substrate
|
|
US8608049B2
(en)
|
2007-10-10 |
2013-12-17 |
Zimmer, Inc. |
Method for bonding a tantalum structure to a cobalt-alloy substrate
|
|
US8114883B2
(en)
*
|
2007-12-04 |
2012-02-14 |
Landec Corporation |
Polymer formulations for delivery of bioactive materials
|
|
WO2009085952A1
(en)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
US20090187256A1
(en)
*
|
2008-01-21 |
2009-07-23 |
Zimmer, Inc. |
Method for forming an integral porous region in a cast implant
|
|
US20090198286A1
(en)
*
|
2008-02-05 |
2009-08-06 |
Zimmer, Inc. |
Bone fracture fixation system
|
|
US8828354B2
(en)
*
|
2008-03-27 |
2014-09-09 |
Warsaw Orthopedic, Inc. |
Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
|
|
WO2009129316A2
(en)
*
|
2008-04-15 |
2009-10-22 |
Etex Corporation |
Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement
|
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US8956641B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
|
US8420114B2
(en)
*
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
|
US9289409B2
(en)
*
|
2008-04-18 |
2016-03-22 |
Warsaw Orthopedic, Inc. |
Sulindac formulations in a biodegradable material
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8557273B2
(en)
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
US20090263451A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
|
|
US8722079B2
(en)
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
|
US8846068B2
(en)
|
2008-04-18 |
2014-09-30 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising a local anesthetic
|
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US9132119B2
(en)
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US9072727B2
(en)
*
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
|
US20090264478A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Sulfasalazine formulations in a biodegradable polymer carrier
|
|
US8524267B2
(en)
*
|
2008-04-18 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Dexamethasone formulations in a biodegradable material
|
|
US20090263489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
|
US8956636B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprosing ketorolac
|
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
|
JP5757864B2
(ja)
|
2008-05-20 |
2015-08-05 |
ニューロジェシックス， インコーポレイテッド |
水溶性アセトアミノフェン類似体
|
|
EP2291084A4
(de)
|
2008-05-20 |
2012-04-25 |
Neurogesx Inc |
Carbonat-prodrugs und verfahren zu ihrer verwendung
|
|
WO2009148580A2
(en)
*
|
2008-06-03 |
2009-12-10 |
Qlt Usa, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
WO2009148579A2
(en)
|
2008-06-03 |
2009-12-10 |
Qlt Usa, Inc. |
Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
|
|
JP5670325B2
(ja)
|
2008-06-19 |
2015-02-18 |
エックスカバリー ホールディング カンパニー エルエルシー |
キナーゼ阻害化合物としての置換されたピリダジンカルボキサミド化合物
|
|
AU2009270936B2
(en)
|
2008-07-15 |
2014-12-18 |
Theracos, Inc. |
Deuterated benzylbenzene derivatives and methods of use
|
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
|
US20100015049A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
|
|
US9492375B2
(en)
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
|
CN103910702A
(zh)
|
2008-08-22 |
2014-07-09 |
泰拉科斯有限公司 |
制备sglt2抑制剂的方法
|
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
|
US12171463B2
(en)
|
2008-10-03 |
2024-12-24 |
Femasys Inc. |
Contrast agent generation and injection system for sonographic imaging
|
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
|
US9161903B2
(en)
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
|
BRPI0921494A2
(pt)
|
2008-11-03 |
2018-10-30 |
Prad Reasearch And Development Ltd |
método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
|
|
WO2010068483A2
(en)
|
2008-11-25 |
2010-06-17 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
US8822610B2
(en)
|
2008-12-22 |
2014-09-02 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
US8815971B2
(en)
|
2008-12-22 |
2014-08-26 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
US8980317B2
(en)
|
2008-12-23 |
2015-03-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating infections comprising a local anesthetic
|
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
|
US20100226959A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Matrix that prolongs growth factor release
|
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
US9078712B2
(en)
|
2009-04-15 |
2015-07-14 |
Warsaw Orthopedic, Inc. |
Preformed drug-eluting device to be affixed to an anterior spinal plate
|
|
US9414864B2
(en)
|
2009-04-15 |
2016-08-16 |
Warsaw Orthopedic, Inc. |
Anterior spinal plate with preformed drug-eluting device affixed thereto
|
|
US8173750B2
(en)
|
2009-04-23 |
2012-05-08 |
ATRP Solutions, Inc. |
Star macromolecules for personal and home care
|
|
WO2010123574A1
(en)
|
2009-04-23 |
2010-10-28 |
Atrp Solutions Inc |
Star macromolecules for personal and home care
|
|
US9783628B2
(en)
|
2009-04-23 |
2017-10-10 |
ATRP Solutions, Inc. |
Dual-mechanism thickening agents for hydraulic fracturing fluids
|
|
US8889161B2
(en)
*
|
2009-04-27 |
2014-11-18 |
Premier Dental Products Company |
Microencapsulated compositions and methods for tissue mineralization
|
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
|
US8617583B2
(en)
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
|
US8653029B2
(en)
|
2009-07-30 |
2014-02-18 |
Warsaw Orthopedic, Inc. |
Flowable paste and putty bone void filler
|
|
US8231891B2
(en)
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
|
TWM373127U
(en)
*
|
2009-08-06 |
2010-02-01 |
Liang-Yang Lin |
disassembleable warm-keeping clothing set formed of solar nano-carbon balls composite material
|
|
KR20120107070A
(ko)
*
|
2009-09-22 |
2012-09-28 |
에보닉 데구사 코포레이션 |
다양한 생리활성 물질 로딩 구성을 갖는 임플란트 장치
|
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
US9504698B2
(en)
*
|
2009-10-29 |
2016-11-29 |
Warsaw Orthopedic, Inc. |
Flowable composition that sets to a substantially non-flowable state
|
|
US9839609B2
(en)
|
2009-10-30 |
2017-12-12 |
Abela Pharmaceuticals, Inc. |
Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
|
|
US8597192B2
(en)
|
2009-10-30 |
2013-12-03 |
Warsaw Orthopedic, Inc. |
Ultrasonic devices and methods to diagnose pain generators
|
|
US8758791B2
(en)
*
|
2010-01-26 |
2014-06-24 |
Warsaw Orthopedic, Inc. |
Highly compression resistant matrix with porous skeleton
|
|
US8475824B2
(en)
*
|
2010-01-26 |
2013-07-02 |
Warsaw Orthopedic, Inc. |
Resorbable matrix having elongated particles
|
|
US9050274B2
(en)
*
|
2010-01-28 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
|
|
US9486500B2
(en)
|
2010-01-28 |
2016-11-08 |
Warsaw Orthopedic, Inc. |
Osteoimplant and methods for making
|
|
US9125902B2
(en)
*
|
2010-01-28 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Methods for treating an intervertebral disc using local analgesics
|
|
WO2011145083A2
(en)
|
2010-05-20 |
2011-11-24 |
Ecolab Usa Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
|
JP6086326B2
(ja)
|
2010-05-24 |
2017-03-01 |
ユニヴァーシティー オブ ロチェスター |
二環式ヘテロアリールキナーゼ阻害剤および使用方法
|
|
PL2394663T3
(pl)
|
2010-05-31 |
2022-02-21 |
Laboratorios Farmaceuticos Rovi, S.A. |
Kompozycje do wstrzykiwania implantów biodegradowalnych in-situ
|
|
GB2513060B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
|
GB2513267B
(en)
|
2010-06-08 |
2015-03-18 |
Rb Pharmaceuticals Ltd |
Injectable flowable composition comprising buprenorphine
|
|
WO2011153712A1
(en)
|
2010-06-12 |
2011-12-15 |
Theracos, Inc. |
Crystalline form of benzylbenzene sglt2 inhibitor
|
|
EP3597226A1
(de)
*
|
2010-08-10 |
2020-01-22 |
Lifecell Corporation |
Regenerative gewebegerüste
|
|
US8246571B2
(en)
|
2010-08-24 |
2012-08-21 |
Warsaw Orthopedic, Inc. |
Drug storage and delivery device having a retaining member
|
|
PL2625176T3
(pl)
|
2010-10-08 |
2017-08-31 |
Xcovery Holding Company Llc |
Podstawione związki 6-amino-pirydazyn-3-ylo-karboksyamidu jako modulatory kinazy białkowej
|
|
US8740982B2
(en)
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
|
US8404268B2
(en)
|
2010-10-26 |
2013-03-26 |
Kyphon Sarl |
Locally targeted anti-fibrotic agents and methods of use
|
|
US9414930B2
(en)
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
|
US8623396B2
(en)
|
2010-12-03 |
2014-01-07 |
Warsaw Orthopedic, Inc. |
Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
|
|
US9301946B2
(en)
|
2010-12-03 |
2016-04-05 |
Warsaw Orthopedic, Inc. |
Clonidine and GABA compounds in a biodegradable polymer carrier
|
|
US9587064B2
(en)
|
2010-12-08 |
2017-03-07 |
ATRP Solutions, Inc. |
Salt-tolerant star macromolecules
|
|
US9060978B2
(en)
|
2011-01-24 |
2015-06-23 |
Warsaw Orthopedic, Inc. |
Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
|
|
US9717779B2
(en)
|
2011-01-31 |
2017-08-01 |
Warsaw Orthopedic, Inc. |
Implantable matrix having optimum ligand concentrations
|
|
EP3502236B1
(de)
|
2011-02-18 |
2023-08-23 |
The Scripps Research Institute |
Gezielte differenzierung von oligodendrozyten-vorläuferzellen zu einem myelinierungszellenschicksal
|
|
CA2827330A1
(en)
*
|
2011-02-23 |
2012-08-30 |
Ams Research Corporation |
Pelvic implant and therapeutic agent system and method
|
|
US9592243B2
(en)
|
2011-04-25 |
2017-03-14 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for treatment of an injury
|
|
US9511077B2
(en)
|
2011-04-25 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for wound healing
|
|
US8524664B2
(en)
|
2011-06-02 |
2013-09-03 |
Colorado Seminary, Which owns and Operates The Univeristy of Denver |
Methods of treating overproduction of cortisol using ACTH antagonist peptides
|
|
US9132194B2
(en)
|
2011-07-12 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive sheet containing a drug depot
|
|
US9205241B2
(en)
|
2011-07-12 |
2015-12-08 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive material
|
|
US9877929B2
(en)
|
2011-10-13 |
2018-01-30 |
Premier Dental Products Company |
Topical vitamin D and ubiquinol oral supplement compositions
|
|
WO2013123509A1
(en)
*
|
2012-02-17 |
2013-08-22 |
Bacterin International, Inc. |
Adjustable bioactive agent dispersion within a polymeric coating
|
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
|
US8735504B2
(en)
|
2012-05-02 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Methods for preparing polymers having low residual monomer content
|
|
CN105189643B
(zh)
|
2012-08-30 |
2019-01-15 |
派诺聚合物技术公司 |
用于水力压裂液的双重机制增稠剂
|
|
US9724542B2
(en)
|
2012-10-12 |
2017-08-08 |
Premier Dental Products Company |
Remineralizing and desensitizing compositions, treatments and methods of manufacture
|
|
US9877930B2
(en)
|
2012-10-12 |
2018-01-30 |
Premier Dental Products Company |
Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
|
|
CN104884059B
(zh)
|
2012-11-30 |
2018-08-10 |
罗切斯特大学 |
用于hiv/aids治疗的混合谱系激酶抑制剂
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
EP2951220B1
(de)
|
2013-02-04 |
2020-11-25 |
Pilot Polymer Technologies, Inc. |
Salztolerante sternmakromoleküle
|
|
US9663707B2
(en)
*
|
2013-10-23 |
2017-05-30 |
Baker Hughes Incorporated |
Stimulation method using biodegradable zirconium crosslinker
|
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
|
EP4268860A3
(de)
|
2014-06-27 |
2024-01-17 |
Boston Scientific Scimed, Inc. |
Zusammensetzungen, vorrichtungen, kits und verfahren zur anbringung von stenthaltigen medizinischen vorrichtungen auf gewebe
|
|
CN107075015B
(zh)
|
2014-07-03 |
2019-08-23 |
派诺聚合物技术公司 |
表面活性剂-相容性星形大分子
|
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
US10080877B2
(en)
|
2014-07-25 |
2018-09-25 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a drug cartridge
|
|
US20160106804A1
(en)
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
|
CA3015557C
(en)
|
2014-11-07 |
2019-07-16 |
Indivior Uk Limited |
The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
|
|
KR101891046B1
(ko)
*
|
2014-12-16 |
2018-08-22 |
보스톤 싸이엔티픽 싸이메드 인코포레이티드 |
생분해성 중합체 조성물
|
|
JP6994638B2
(ja)
*
|
2015-10-09 |
2022-02-21 |
パーティクル３ディー アプス |
３ｄ印刷用供給原料およびその使用
|
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
|
USD802757S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
|
MX390005B
(es)
|
2016-10-03 |
2025-03-20 |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Inhibidores selectivos de jak1 novedosos y usos de los mismos.
|
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
|
KR101942449B1
(ko)
*
|
2016-12-13 |
2019-01-28 |
주식회사 삼양바이오팜 |
생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러
|
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
|
GB2568526A
(en)
*
|
2017-11-20 |
2019-05-22 |
Rebio Tech Oy |
Composition
|
|
US11717555B2
(en)
|
2017-12-18 |
2023-08-08 |
Foresee Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions having a selected release duration
|
|
BR112020022294A2
(pt)
|
2018-05-04 |
2021-02-23 |
Tollys |
composição e uso de uma composição
|
|
PE20210047A1
(es)
|
2018-06-12 |
2021-01-08 |
Farm Rovi Lab Sa |
Composicion inyectable
|
|
GB201900258D0
(en)
|
2019-01-08 |
2019-02-27 |
Medincell |
Pharmaceutical composition
|
|
AU2020257624B2
(en)
*
|
2019-04-18 |
2026-01-29 |
DePuy Synthes Products, Inc. |
Biocompatible organogel matrices for intraoperative preparation of a drug delivery depot
|
|
GB202010340D0
(en)
*
|
2020-07-06 |
2020-08-19 |
Medincell |
Pharmaceutical composition
|
|
EP4239026A4
(de)
*
|
2020-10-30 |
2024-11-06 |
Toray Industries, Inc. |
Polymerzusammensetzung und formartikel
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
US12594236B2
(en)
|
2021-07-16 |
2026-04-07 |
Laboratorios Farmaceuticos Rovi, S.A. |
Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
|
|
US12318387B2
(en)
|
2021-07-16 |
2025-06-03 |
Laboratorios Farmaceuticos Rovi, S.A. |
Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
|
|
EP4385510A4
(de)
|
2021-08-10 |
2025-08-20 |
Betta Pharmaceuticals Co Ltd |
Verwendung von ensartinib oder einem salz davon bei der behandlung von krankheiten mit exon-skipping-mutation von met 14
|
|
TW202313047A
(zh)
|
2021-09-21 |
2023-04-01 |
西班牙商禾霏藥品實驗室有限公司 |
抗精神病可注射儲積型組合物
|
|
CA3248062A1
(en)
|
2022-05-18 |
2025-07-10 |
Laboratorios Farmacéuticos Rovi, S.A. |
Extended-release injectable compositions intended for use in treatment with risperidone in conjunction with CYP2D6 enzyme inhibitors
|
|
WO2025126109A1
(en)
|
2023-12-15 |
2025-06-19 |
Ensem Therapeutics, Inc. |
Anilino-pyrazole derivatives, compositions and methods thereof
|